+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Parabolic Drugs Ltd (PARABDRUGS) - Financial and Strategic SWOT Analysis Review

  • ID: 4281482
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData

Parabolic Drugs Ltd (PDL) is a pharmaceutical manufacturer and exporter that develops and manufactures active pharmaceutical ingredients and API intermediates. The company operates through its business units such as oral and sterile semi synthetic penicillins, oral and sterile cephalosporins, non-antibiotics, intermediates and high potent active ingredients. It offers cephalasporin oral products including cefuroxime axetil, cefpodoxime proxetil, cefixime trihydrate, cefdinir, and cefprozil, among others. PDL provides cephalosporin sterile products such as ceftriaxone sodium, cefuroxime sodium, ceftazidime, cefotaxime sodium and cefalotin sodium, among others. The company also provides custom research and manufacturing services to pharmaceutical companies. It operates through its manufacturing facilities located in Punjab and Haryana, India. The company has operations in Middle-East, the UK, Africa, China, Korea, Japan, Latin America, the US, and others. PDL is headquartered in Chandigarh, Punjab, India.

Parabolic Drugs Ltd Key Recent Developments

May 10, 2017: Parabolic Drugs Appoints Ashok Kumar Jindal As Chief Financial Officer

This comprehensive SWOT profile of Parabolic Drugs Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Parabolic Drugs Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Parabolic Drugs Ltd - Key Information
  • Parabolic Drugs Ltd - Overview
  • Parabolic Drugs Ltd - Key Employees
  • Parabolic Drugs Ltd - Key Employee Biographies
  • Parabolic Drugs Ltd - Key Operational Heads
  • Parabolic Drugs Ltd - Major Products and Services
  • Parabolic Drugs Ltd - History
  • Parabolic Drugs Ltd - Company Statement
  • Parabolic Drugs Ltd - Locations And Subsidiaries
  • Parabolic Drugs Ltd - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Parabolic Drugs Ltd - Business Description
  • Parabolic Drugs Ltd - Corporate Strategy
  • Parabolic Drugs Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Parabolic Drugs Ltd - Strengths
  • Parabolic Drugs Ltd - Weaknesses
  • Parabolic Drugs Ltd - Opportunities
  • Parabolic Drugs Ltd - Threats
  • Parabolic Drugs Ltd - Key Competitors
Section 3 - Company Financial Performance Charts
  • Parabolic Drugs Ltd - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Parabolic Drugs Ltd, Key Information
  • Parabolic Drugs Ltd, Key Ratios
  • Parabolic Drugs Ltd, Share Data
  • Parabolic Drugs Ltd, Major Products and Services
  • Parabolic Drugs Ltd, History
  • Parabolic Drugs Ltd, Key Employees
  • Parabolic Drugs Ltd, Key Employee Biographies
  • Parabolic Drugs Ltd, Key Operational Heads
  • Parabolic Drugs Ltd, Other Locations
  • Parabolic Drugs Ltd, Subsidiaries
  • Parabolic Drugs Ltd, Key Manufacturing facilities
  • Parabolic Drugs Ltd, Key Competitors
  • Parabolic Drugs Ltd, SWOT Analysis
  • Parabolic Drugs Ltd, Ratios based on current share price
  • Parabolic Drugs Ltd, Annual Ratios
  • Parabolic Drugs Ltd, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Parabolic Drugs Ltd, Performance Chart
  • Parabolic Drugs Ltd, Ratio Charts
Note: Product cover images may vary from those shown